RUNX3 and neoplasm: Specifically, two breast cancer risk genes in the 26 identified genes, RUNX3 and CXCR6, have high positive correlation in both immune cell types and higher expressions in tumor samples than normal samples, suggesting that these genes could act as antigens on tumor cells in breast cancer.